📄 Extracted Text (1,143 words)
MEMORANDUM OF TERMS FOR PRIVATE PLACEMENT OF SERIES C PREFERRED STOCK
OF COINBASE GLOBAL INC.
October 24, 2014
This memorandum (the "Term Sheer) summarizes the principal terms of a proposed venture
capital financing for Coinbase Global Inc. (the "Company"). The completion of the transactions
contemplated by this memorandum will be subject to, among other things, satisfactory completion of
financial and legal due diligence by DFJ Growth and its partners and affiliates ("DFJ Growth"), as well
as execution of final transaction documents acceptable to DFJ Growth and the Company.
Offering Terms
Issuer: Coinbase Global Inc. (the Company")
Investor:
Investor Name Amount
DFJ Growth $25.0M
Other Investors $17.0 — 45.0 M
Total Investment Up to $70.0M
'Other Investors" shall include existing investors and new investors
to be determined by the Company in its sole discretion.
Securities to be issued: Series C Preferred Stock (the "Series C Preferred")
Price: [TBD] per share of Series C Preferred, reflecting a fully-diluted
pm-money valuation of $400.0 million. Assuming a total Series
C financing of $50.0 million, the post-money valuation shall be
$450.0 million based on the expected pro forma post-closing
capitalization of the Company. To the extent the pm-money
capitalization differs from that assumed in Exhibit A, the price
per share shall be adjusted accordingly.
Option Pool: Upon closing the Series C Preferred financing, the Company's
stock option pool shall have at least 8.0% of the Company's
fully-diluted equity shares unallocated and available for
issuance of future stock option grants. Any expansion of the
option pool needed to meet this requirement shall be included in
the pre-money valuation.
Expected Closing Date: One or more closings to occur within 90 days after execution of
this Term Sheet (the "Expected Closing Date"), where the
first closing shall include at least $39.6 million of investment
from DFJ Growth and existing investors within 30 days after
execution of this Term Sheet.
Terms of Series C Preferred Stock
Certificate of Incorporation
Liquidation Preference: In the event of a liquidation, dissolution or winding-up, the
proceeds shall be distributed to the stockholders as follows:
OHSUSA:759340828.2 1
EFTA01121035
First, the Preferred Stock (Series A, B, C) shall be paid one times
(IX) their respective original purchase price (on a pari-passu
basis) plus declared but unpaid dividends. Thereafter, the
Common Stock and FF Preferred Stock shall share any
remaining proceeds on an as-convened basis.
Dividends: Same structure as Series B
Redemption: Same structure as Series B
Automatic Conversion: Series C Preferred shall automatically convert into Common
Stock upon (i) the election of at least a majority of the
outstanding shares of Series C Preferred, or (ii) the
consummation of an underwritten public offering with aggregate
proceeds in excess of $50,000,000 (a "Qualified Public
Offering").
Price-Based Antidilution: Same structure as Series B
Other Antidilution Adjustments Same structure as Series B
Voting Rights: Series C Preferred votes on an as-convened basis, but also has a
series and class vote as provided by law.
Same protective provisions as the Series B investment
documents and requiring majority approval of the Series A, B
and C Preferred Stock (together, the "Preferred Stock").
Same series-based protective provisions as the Series B
Preferred for the Series C Preferred class and requiring majority
approval of the Series C Preferred.
Preferred Stock Purchase Agreement
Representations and
Warranties: Same structure as Series B
Conditions to Closing: Same structure as Series B
Expenses: Counsel to the Company will draft the investment documents.
The Company shall pay, at the closing, reasonable legal fees and
due diligence expenses of Investor not to exceed $35,000.
Investor Rights Agreement
Registration Rights: Same structure as Series B
Right of First Offer: Same structure as Series B
Financial Information: DR! Growth shall be treated as a Major Holder and shall have
information rights consistent with other major Preferred
investors.
OHSUSA:759340828.2
EFTA01121036
Board Composition: The size and composition of the board of directors (the "Board")
shall be determined by the Company and existing investors. If the
size of the Board is expanded as part of the Series C financing,
then DFJ Growth shall have the right to designate one Board
member and the two directors designated by a majority of the
Common Stock and FF Preferred Stock held by Brian Armstrong
and Fred Ehrsam (the "Founder Directors") shall be entitled to
two (2) votes each on all matters submitted to the Board (i.e. an
aggregate of four (4) votes). If the size of the Board remains
unchanged at the time of the Series C financing, then DEL Growth
shall have the right to designate one Board member at any time
after the Board composition is expanded from its current size, at
which time each Founder Director shall be entitled to two (2)
votes (i.e. an aggregate of four (4) votes). DFJ Growth shall have
the right to designate a non-voting observer to participate in
Board meetings. In each case, the DFJ Growth Board member or
Board observer, as applicable, shall initially be Barry Schuler,
unless otherwise approved by the company. Approval shall not be
unreasonably withheld.
Other Matters
Right of First Refusal and Co-Sale: Same structure as Series B
Drag Along: Same structure as Series B
Management Rights Letter: At the closing, DFJ Growth shall receive a customary
management rights letter in a form reasonably acceptable to
DFJ Growth, which will include standard inspection rights and
board observation rights for DFJ Growth.
Disproportionate Adverse Changes: The rights of the Series C Preferred in the ancillary financing
documents shall not be adversely affected in a manner different
than the rights of the other series of Preferred Stock without the
consent of the holders of a majority of the Series C Preferred.
Confidentiality: Except as required by law, the Company will not discuss the
terms of this Term Sheet with any person other than key
officers, members of the Board of the Company or the
Company's accountants or attorneys without the written
consent of the Investors.
No Shop: From the signing date hereof until 5:00 P.M. Pacific Time on the
Expected Closing Date, other than in connection with the
allocation of the Series C Preferred financing to other investors
contemplated by this Term Sheet, the Company agrees that it
shall not solicit, encourage others to solicit, or encourage or
accept any offers for another preferred stock equity financing or
sale of the Company, and it shall not negotiate with or enter
into any agreement or understanding with any other person with
respect to any such transaction.
OHSUSA:759340828.2 1
EFTA01121037
The failure to execute and deliver a definitive agreement shall impose no liability on DFJ Growth, any
Investors or the Company. If not accepted and executed by 5:00 P.M. Pacific Time on October 25, 2014,
this term sheet shall expire.
AGREED AND ACCEPTED:
DFJ GROWTH COINBASE GLOBAL, INC.
C
By: torl.S.
By:
Name: Barry M. Schuler Name: Fred Ehrsam
Date: 10/24/2014 Date: 10/25/2014 3:36 PM PT
OHSUSA:759340828.2 4
EFTA01121038
ℹ️ Document Details
SHA-256
0e624745e189e839b29a92a9d27032e41ac8644c06ee78f67bc25458b5f8d69a
Bates Number
EFTA01121035
Dataset
DataSet-9
Document Type
document
Pages
4
Comments 0